Hosted on MSN18d
Já podem encomendar o novo Renault 4 E-Tech
Os preços do novo Renault 4 E-Tech começam nos 29.500€. Estão abertas as encomendas do Renault 4 E-Tech elétrico, a versão elétrica do clássico modelo 4L, agora adaptado às exigências ...
BioPharma Dive6d
Novo adds to obesity drug pipeline via $200M deal with China-based biotech
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...
STAT2d
Novo Nordisk sets sights on new type of oral obesity drug
Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...
Reuters4d
Novo shares on track for biggest monthly fall since 2002, investor worries grow
LONDON, March 27 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries ...
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
Reuters3d
BoFA says Novo Nordisk may miss Q1 expectations as Wegovy, Ozempic sales lag
GDANSK/LONDON, March 28 (Reuters) - Bank of America analysts on Friday said Novo Nordisk (NOVOb.CO), opens new tab may miss first-quarter expectations, as sales of its blockbuster Wegovy and ...
FierceBiotech20d
Novo Nordisk links CagriSema to 16% weight loss, sending stock down again
Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. Three months after missing that target in its first phase 3 CagriSema trial, the Danish drugmaker has fallen ...
MarketWatch6d
Novo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drug
Novo Nordisk announced Monday a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the Danish company is currently the leading player. Novo Nordisk said it’s ...
Yahoo Finance21d
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
Bagsværd, Denmark, 10 March 2025 – Today, Novo Nordisk announced headline results ... (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to placebo.
New York Post25d
Novo Nordisk slashing price of Wegovy to $499 a month to uninsured following rival’s move
US-listed shares of Novo were up 4.2% to $91.16 in morning trading. Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Wegovy while the medicines were in ...
Investopedia25d
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
Shares of Novo Nordisk rose close to 4% intraday Wednesday, but have lost about a quarter of their value over the past 12 months. CORRECTION—March 5, 2025: This article has been corrected to ...